RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Summary

This phase II trial studies how well RO4929097 works in treating patients with metastatic colorectal cancer. RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2010-05

Primary completion

2011-05

Completion

2012-03

Drugs

Indications